Results
2
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
2 companies
argenx
Market Cap: €31.4b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€521.80
7D
9.3%
1Y
52.9%
UCB
Market Cap: €30.6b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€163.65
7D
6.2%
1Y
28.3%